Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma. [electronic resource]
Producer: 19870724Description: S27-33 p. digitalISSN:- 0167-6997
- Adult
- Aged
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Clinical Trials as Topic
- Cyclophosphamide -- adverse effects
- Female
- Humans
- Interferon Type I -- adverse effects
- Lymphoma, Non-Hodgkin -- therapy
- Male
- Middle Aged
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.